Newsroom

Molecular Information-based Collaboration Focuses on Integrating Comprehensive Genomic Profiling into Clinical Trials to Enable Patient Access...

$12 million research project aimed at demonstrating the quality assurance of oncology nurse navigation to improve care and outcomes

Joint clinical development will study the combination of two checkpoint inhibitors from Boehringer Ingelheim's growing immune-oncology pipeline

Ticket On-Sale Begins August 5 at 10 a.m. at bandagainstcancer.com; The Sarah Cannon Tour aims to connect people facing blood cancer with community...

Sarah Cannon is pleased to announce the promotion of Erika P. Hamilton, MD, to director, breast and gynecologic cancer research program.

Sarah Cannon is pleased to announce the promotion of David Spigel, MD, to chief scientific officer.

Research team members to discuss more than 100 presentations related to latest data and innovations for advancing cancer therapies

The Sarah Cannon Tour brings together two of the most influential industries to connect people facing cancer with community resources through...